Company / Working Capital per Share
Haemonetics Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$7.03
FY2025
5-year range
$6.10 / $10.08
FY2021-FY2025
Trend
-24.3%
vs FY2024
Sector context
#64 of 163
Health Care
What the data says
At $7.03, Haemonetics's working capital per share ranks #64 of 163 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $2.61 in FY2018 to $10.08 in FY2023.
Based on SEC 10-K filings.
7.03 in FY2025 with a 5-year CAGR of +1.9%.
Declined from $10.08 to $7.03 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +4.8%
- 5-Year CAGR
- +1.9%
- 10-Year CAGR
- -
Sector benchmark
#64 of 163 in Health CareTop 39% of 163This company $7.03 Sector average $24.09
▼
-70.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 24.3% year-over-year.
- Ranks #64 out of 163 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2023.
- Lowest working capital per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.03 | -24.3% |
| FY2024 | $9.29 | -7.8% |
| FY2023 | $10.08 | +65.1% |
| FY2022 | $6.10 | -28.8% |
| FY2021 | $8.57 | +33.7% |
| FY2020 | $6.41 | -2.4% |
| FY2019 | $6.57 | +151.5% |
| FY2018 | $2.61 | -55.5% |
| FY2017 | $5.87 | +0.2% |
| FY2016 | $5.86 | -17.4% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026